GNH USA

Europe — EMA

Yesintek

Yesintek (ustekinumab) is a biologic therapy used for immune-mediated conditions. It works by modulating specific immune pathways to reduce inflammation. This E

Ustekinumab

Request sourcing

1
Pack/s

What is Ustekinumab?

Yesintek (ustekinumab) is a biologic therapy used for immune-mediated conditions. It works by modulating specific immune pathways to reduce inflammation. This EU-approved biosimilar offers an alternative to branded biologics for targeted treatment. Ideal for patients seeking cost-effective immune support.

What is Ustekinumab used for?

Ustekinumab is commonly used to manage immune-related disorders such as moderate to severe plaque psoriasis and active psoriatic arthritis. It may also be prescribed for moderate to severe Crohn’s disease or ulcerative colitis in adults who have not responded to conventional therapies. Patients often ask, 'what is ustekinumab used for' when exploring treatment options for chronic inflammatory conditions.

What are the side effects of Ustekinumab?

This medication helps reduce symptoms like joint pain, skin plaques, and gastrointestinal discomfort by targeting specific proteins involved in inflammation. Users may notice gradual improvement in their condition over several weeks of consistent use. Individual responses can vary based on the underlying health issue being treated.

What precautions apply to Ustekinumab?

Store Yesintek in a refrigerator until ready for use, but avoid freezing. Keep the medication in its original packaging to protect it from light. Always check the solution for particles or discoloration before administration. Discard any unused portion as directed by a healthcare provider.

What does Ustekinumab interact with?

Ustekinumab may interact with live vaccines, so avoid vaccination during treatment unless approved by a doctor. Caution is advised when combining with other immunosuppressants, as the effects on the immune system could be additive. Always inform your healthcare provider about all medications you are taking.

Frequently asked questions

How long does it take for ustekinumab to work?+
Symptom improvement may take several weeks, with some patients noticing changes within 2–4 weeks of starting treatment.
Can I use ustekinumab while pregnant?+
Consult a healthcare provider to weigh potential risks and benefits, as the effects on pregnancy are not fully established.
Is Yesintek a biosimilar?+
Yes, Yesintek is a biosimilar to the reference biologic, offering a similar therapeutic effect at a potentially lower cost.
How often is ustekinumab administered?+
Dosage frequency typically ranges from every 12 weeks to every 8 weeks, depending on the condition being treated.
What should I do if I miss a dose of ustekinumab?+
Contact your healthcare provider for guidance; do not take a double dose to make up for a missed one.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ustekinumab
Route
Subcutaneous Use
Manufacturer
Biosimilar Collaborations Ireland Limited
Origin
EU

Related products